4/13/2004

Preliminary results of a trial suggest children are at risk for learning and behavioral problems if their mothers are treated with terbutaline, often prescribed for stopping preterm labor. Such use is off-label, because the FDA has approved the drug only for treating asthma, and researchers say their studies suggest terbutaline exposure could leave a child's brain vulnerable to the harmful effects of other chemicals, such as pesticides.

Related Summaries